Definitive Contract HHSN261201700022C
Award Date
9/15/17
Potential Completion Date
6/14/18
Potential Value
$299K
Federal Agency
National Cancer Institute
Awardee
Aethlon Medical Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92123, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $197,673 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a part of the Department of Health and Human Services (HHS), to Molecular Express, Inc., a minority-owned and self-certified small disadvantaged business. The contract is for the development of a commercial point-of-care device capable of electronically sensing tumor cells and molecular cancer biomarkers in a patient's circulating peripheral blood. This research project...
This is a $399,062 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Avoneaux Medical Institute, LLC for the development of spatial micro-purification technology. The contract was set aside for small businesses and is part of the NCI's broader SBIR program, which funds research and development in support of the NIH and CDC's mission needs. The original solicitation sought proposals on a range of cancer-related topics, including alternatives to cell...
This federal contract award, valued at $400,000.00, was issued by the National Cancer Institute (NCI) to Elate Medical, Inc., a small business located in Houston, Texas. The contract is for the Small Business Innovation Research (SBIR) Phase I effort under Topic 445 - "Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-based Therapies". The ultimate completion date for this Firm Fixed Price contract is September 14, 2023. This SBIR contract opportunity was...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of "functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles" for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...
<p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanospectra Biosciences, Inc. for "Targeted Photothermal Ablation of Melanoma". The contract has a firm fixed price ceiling of $200,000.00 and a period of performance ending on September 23, 2011. As an SBIR Phase I award, this contract is focused on feasibility research and development of the proposed technology.</p>
This is a $599,998.00 firm fixed price contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Melax Technologies Inc., a for-profit small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, which does not have a set-aside designation, to conduct research and development of advanced data analytics technologies focused on healthcare applications. The work is being performed in Houston,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Atux Iskay Group LLC, a for-profit limited liability company. The $400,000 firm-fixed price contract will support the development of senotherapeutic agents for cancer treatment. This is a total small business set-aside contract, with work to be performed primarily in Plainsboro Township, New Jersey. The contract stems from a...
This is a $200,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Nanomaterial Innovation LTD, a woman-owned limited liability company. The contract is for the development of "MULTIFUNCTIONAL SIRNA NANOPARTICLES FOR AML THERAPY", which aligns with NCI's research focus on cancer therapeutics. The contract has a firm fixed price pricing type and was awarded on September 24, 2010 with a...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, for the development of "small hollow nanodelivery vehicles for cancer treatment." The fixed-price contract has a ceiling value of $200,000.00 and a period of performance ending on March 30, 2010. Nanocomposix has previously performed prime contracts and subcontracts for...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...